[1]
2023. Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study. Swiss Medical Weekly. 153, 3 (Mar. 2023), 40055. DOI:https://doi.org/10.57187/smw.2023.40055.